ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

Grand Jury Clears Eppley, Shubik

October 24, 1980

Tempero, Johnson To Lead ASCO

March 28, 2003

In Brief: Ford To Go Along With Cooper As Health Chief, Fredrickson As NIH Director, W.H. Sources Says

March 14, 1975

Consolidation Unlikely to Save Money

December 17, 2010